Page 3 - Avan Yu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Atlantic The reputation of all COVID-19 vaccines hinges on improving perceptions of the Johnson & Johnson shot. The Atlantic / Flavio Coelho / Getty Had Johnson & Johnson’s COVID-19 vaccine been the first to get the FDA’s green light, it might have been hailed from the get-go for what it actually is: a scientific and technological marvel. It requires just one injection to confer full immunity—a boon for needlephobes and tough-to-reach populations who can’t easily access a second dose. It’s relatively cheap and has forgiving refrigeration requirements, making it a breeze to ship ...

"We have more than enough supply of Pfizer and Moderna vaccines to continue the current pace of about 3 million shots per day," Zients told reporters at a press briefing. So far, this has held true. The country is averaging 3.3 million daily vaccine doses reported administered over the past week, and 3 million when counting only Pfizer and Moderna. Only about 7.8 million of the 202 million total shots given in the U.S. have been from J&J, according to Centers for Disease Control and Prevention data. But the single-shot Johnson & Johnson vaccine does represent about 10% of all fully vaccinated...